Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03286231 · ClinicalTrials.gov registry record

Anti-FLEX: Flexed Levering of Gluteal Vessels

A clinical trial, sponsored by University of South Florida.

Completed
Registry status
11
Enrollment target

NCT03286231: Completed study, sponsored by University of South Florida.

NCT03286231 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03286231 has completed, sponsored by University of South Florida.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effect of the gluteal vasculature in the prone and jackknife positions.

Primary Outcome

Between the Prone position and the Jackknife position

Interventions

  • DIAGNOSTIC_TEST CT imaging

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2018-05-03
Est. Completion 2020-01-13
University of South Florida

252 total trials

What the finished NCT03286231 record still lists

NCT03286231 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which CT imaging is the first listed.

NCT03286231 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03286231 about?

NCT03286231 is a clinical study titled "Anti-FLEX: Flexed Levering of Gluteal Vessels". The purpose of this study is to evaluate the effect of the gluteal vasculature in the prone and jackknife positions.

What is the current status of trial NCT03286231?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2018-05-03. Estimated completion is 2020-01-13.

What interventions are being tested in trial NCT03286231?

The interventions under investigation include: CT imaging (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03286231?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03286231, the US trial registry maintained by the National Library of Medicine. NCT03286231 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.